Copyright: ©Author(s) 2026.
Artif Intell Gastroenterol. Aug 8, 2026; 7(2): 120311
Published online Aug 8, 2026. doi: 10.35712/aig.120311
Published online Aug 8, 2026. doi: 10.35712/aig.120311
Table 2 Prognostic vs predictive modeling in advanced hepatocellular carcinoma
| Feature | Prognostic model | Predictive model |
| Core question | What is the patient’s outcome risk? | Does the patient benefit more from treatment A vs B? |
| Treatment consideration | Ignored or uniform | Central to model structure |
| Typical dataset | Single-treatment cohort | Multi-treatment or counterfactual framework |
| Key bias risk | Overfitting | Confounding by indication |
| Statistical requirement | Discrimination and calibration | Causal inference methods (propensity modeling, counterfactual ML, uplift models) |
| Clinical utility | Risk stratification | Therapy selection guidance |
- Citation: Meena BL, Behera B, Rudra OS, Sharma D. Artificial intelligence in prognostication and treatment response modeling in advanced hepatocellular carcinoma. Artif Intell Gastroenterol 2026; 7(2): 120311
- URL: https://www.wjgnet.com/2644-3236/full/v7/i2/120311.htm
- DOI: https://dx.doi.org/10.35712/aig.120311